Literature DB >> 25301102

siRNA liposome-gold nanorod vectors for multispectral optoacoustic tomography theranostics.

Adrian Taruttis1, Neus Lozano, Antonio Nunes, Dhifaf A Jasim, Nicolas Beziere, Eva Herzog, Kostas Kostarelos, Vasilis Ntziachristos.   

Abstract

Therapeutic applications of gene silencing using siRNA have seen increasing interest over the past decade. The optimization of the delivery and biodistribution of siRNA using liposome-gold nanorod (AuNRs) nanoscale carriers can greatly benefit from adept imaging methods that can visualize the time-resolved delivery performance of such vectors. In this work, we describe the effect of AuNR length incorporated with liposomes and show their complexation with siRNA as a novel gene delivery vehicle. We demonstrate the application of multispectral optoacoustic tomography (MSOT) to longitudinally visualize the localisation of siRNA carrying liposome-AuNR hybrids within tumors. Combination of in vivo MSOT with ex vivo fluorescence cryo-slice imaging offers further insight into the siRNA transport and activity obtained.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25301102     DOI: 10.1039/c4nr04164j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  10 in total

Review 1.  Oligonucleotide-based theranostic nanoparticles in cancer therapy.

Authors:  Reza Shahbazi; Bulent Ozpolat; Kezban Ulubayram
Journal:  Nanomedicine (Lond)       Date:  2016-04-22       Impact factor: 5.307

Review 2.  Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

Authors:  Zhihang Chen; Balaji Krishnamachary; Jesus Pachecho-Torres; Marie-France Penet; Zaver M Bhujwalla
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-23

3.  Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.

Authors:  Maryam Hajfathalian; Ahmad Amirshaghaghi; Pratap C Naha; Peter Chhour; Jessica C Hsu; Keely Douglas; Yuxi Dong; Chandra M Sehgal; Andrew Tsourkas; Svetlana Neretina; David P Cormode
Journal:  Nanoscale       Date:  2018-10-02       Impact factor: 7.790

4.  PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.

Authors:  Zhihang Chen; Marie-France Penet; Balaji Krishnamachary; Sangeeta R Banerjee; Martin G Pomper; Zaver M Bhujwalla
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

5.  Near-infrared light-sensitive liposomes for enhanced plasmid DNA transfection.

Authors:  Christian Wiraja; Malathi Mathiyazhakan; Fatemeh Movahedi; Paul Kumar Upputuri; Yingying Cheng; Manojit Pramanik; Liang Yang; David Laurence Becker; Chenjie Xu
Journal:  Bioeng Transl Med       Date:  2016-07-29

Review 6.  Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?

Authors:  Pedro Pedrosa; Raquel Vinhas; Alexandra Fernandes; Pedro V Baptista
Journal:  Nanomaterials (Basel)       Date:  2015-11-03       Impact factor: 5.076

7.  Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy.

Authors:  Haiying Hua; Nan Zhang; Dan Liu; Lili Song; Tuanbing Liu; Shasha Li; Yongxing Zhao
Journal:  Int J Nanomedicine       Date:  2017-10-25

8.  Ultra-high thermally stable gold nanorods/radial mesoporous silica and their application in enhanced chemo-photothermal therapy.

Authors:  Chun Shan; Yuting Huang; Junhao Wei; Min Chen; Limin Wu
Journal:  RSC Adv       Date:  2021-03-11       Impact factor: 3.361

9.  Polymer-Peptide Modified Gold Nanorods to Improve Cell Conjugation and Cell labelling for Stem Cells Photoacoustic Imaging.

Authors:  Dina Salah; Farahat S Moghanm; Muhammad Arshad; Abdulaziz A Alanazi; Salman Latif; Maie I El-Gammal; Elmahdy M Shimaa; Salah Elsayed
Journal:  Diagnostics (Basel)       Date:  2021-06-30

10.  Development of amyloid beta gold nanorod aggregates as optoacoustic probes.

Authors:  Mahmoud G Soliman; Hannah A Davies; Jack Sharkey; Raphaël Lévy; Jillian Madine
Journal:  PLoS One       Date:  2022-03-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.